This inventor holds 3 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., Taizhou Fudan-Zhangjiang Pharmaceutical Co., Ltd.. Active years: 2013-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 4 
1 out of 1 Years Active: 2013-2025
Title: Yijun Shen: Innovator in Antibody Development
Introduction
Yijun Shen is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative antibody therapies. With a total of 3 patents to his name, Shen's work focuses on advancing cancer treatment through targeted therapies.
Latest Patents
Shen's latest patents include groundbreaking inventions such as the "Anti-B7-H3 antibody, preparation method therefor, conjugate and application thereof." This fully human antibody is designed to specifically bind to the B7-H3 antigen found on tumor cells. It features a unique antigen binding epitope and can rapidly internalize into cells after binding, making it a promising candidate for antibody-drug conjugate (ADC) drug development aimed at enhancing anti-tumor activity.
Another notable patent is the "Antibody-drug conjugate, and intermediate thereof, preparation method therefor, and application thereof." This invention represents an antibody-drug conjugate that exhibits excellent targetability and inhibitory effects on HER3-positive tumor cells. The compound demonstrates high safety and efficacy against various cancer cell lines, including SK-BR-3 and SW620 cells.
Career Highlights
Yijun Shen has worked with reputable companies in the biopharmaceutical sector, including Shanghai Fudan-Zhangjiang Bio-pharmaceutical Co., Ltd. and Taizhou Fudan-Zhangjiang Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in antibody development and cancer therapeutics.
Collaborations
Shen has collaborated with notable colleagues in his field, including Fang Wu and Tong Yang. These partnerships have likely enhanced his research and development efforts, leading to innovative solutions in biopharmaceuticals.
Conclusion
Yijun Shen is a distinguished inventor whose work in antibody development is paving the way for new cancer treatments. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile